Phase II Study of a Platinum-Based Adapted Chemotherapy Regimen Combined with Radiotherapy in Patients 75 Years and Older with Esophageal Cancer.
about
Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.
P2860
Phase II Study of a Platinum-Based Adapted Chemotherapy Regimen Combined with Radiotherapy in Patients 75 Years and Older with Esophageal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Phase II Study of a Platinum-B ...... Older with Esophageal Cancer.
@en
type
label
Phase II Study of a Platinum-B ...... Older with Esophageal Cancer.
@en
prefLabel
Phase II Study of a Platinum-B ...... Older with Esophageal Cancer.
@en
P2093
P2860
P1433
P1476
Phase II Study of a Platinum-B ...... Older with Esophageal Cancer.
@en
P2093
Bernard Roullet
Gilles Créhange
Jean François Bosset
Marc Puyraveau
Philippe Maingon
Stéphanie Servagi-Vernat
Valentine Guimas
P2860
P2888
P304
P356
10.1007/S40266-015-0275-8
P577
2015-06-01T00:00:00Z
P6179
1017816355